Abiopharma

Safe Pro to Demonstrate AI-Powered Mission Planning at U.S. Army Fort Leonard Wood Maneuver Support Center of Excellence Event

Iovance Biotherapeutics to Report First Quarter 2026 Financial Results and Corporate Updates on Thursday, May 7, 2026

Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF’s Spring Clinical Meetings

Sierra Bancorp Reports First Quarter 2026 Results

BioVie Inc. - BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinsons Disease ahead of Topline Data in 2Q26, on May 7, 2026

Thermo Fisher Scientific - Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg

Cerus Corporation - Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System

Nuvation Bio Inc. - Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib(IBTROZI®) as Recommended Option to Clinical Practice Guidelines in Oncology for Central Nervous System Cancers

Mirum Pharma - Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 2b Portion of the AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus

Allarity Therapeutics Announces that the Stenoparib DRP® Test Has Received a Notice of Allowance from the US Patent and Trademark Office